We have established our own natural materials processing center in Uganda, to develop and discover high quality natural bio-materials in order to lead on the biomaterials market.
01 Shea Butter
'Shea butter' is rich in vegetable fatty acids and contains natural vitamins (A, D, E, F), as well as phytosterols which is related to anti-inflammatory and immune regulation. Shea butter is a natural biomaterial that is also used as a raw material for cosmetics, food and medicine.
3 main competitiveness of Laonz’s shea butter
Quality : Through intensive management and education to local cooperatives, we secure high-quality raw materials from the supply and demand stage of shea kernel, the raw material of shea butter.
Price : Secure price competitiveness by massive production of shea butter with an automated production facility
Effect : Through the cold pressed method of Extra Virgin grade material, provides enhanced effects of the active shea ingredient.
The ‘Laonz Shea Butter project’ is part of the Uganda government and Korea's KOICA IBS project (3.6 billion KRW, 5 years).
The Uganda Shea Butter business was selected as the ‘2019 KOICA IBS’s Excellent Project’.
Withshea is a Shea Value Chain business led by Laonz. It is a sustainable development model that strengthens the capabilities of Ugandan shea fruit growers with abundant resources and potentials, as well as contributes to the development of Ugandan shea business by directly operating processing facilities and reinvests profits through forestation and research.
ONE FINE DAY, only good ingredient in the world makes your companion healthy and happy every day!
Frenshea has a large-scale production facility in Uganda, Africa, It is made with high-quality shea butter produced by cold-pressed method as its main raw material.
Instead of using purified water, Frenshea is formulated based on centella asiatica extract that has excellent anti-inflammatory and skin soothing effects. We have developed the 4care complex (Centella asiatica extract, Shea butter, Moringa, Glycyrrhizic acid) to be optimized in itchiness relief for sensitive, atopic skin.
Joint development with Seoul National University Veterinary Medical Teaching Hospital
Thoroughly verified from development stage to clinical trial with Seoul National University, Veterinary Medical teaching hospital Director Dr. Hwang Cheolyong.
Successfully completed user satisfaction survey at Seoul National University Veterinary Medical Teaching hospital.
"For allergic/atopic dermatitis in pets, it is most important to find the best way to improve the quality of life for their guardians and pets by properly controlling secondary skin problems caused by itching, not just for the purpose of complete healing”.
World's first AI-based early diagnosis medical device for cervical cancer by using deep learning algorithm
Developed by MobileODT, Israel
Result can be checked on site after screening
Result with 92% high accuracy
Patient information protected with HIPPA and GDPR compliance
FDA cleared as Colposcope, CE marked.
Undergoing with FDA approval as the world's first AI diagnostic equipment for cervical cancer.
Registered as domestic medical device from the Ministry of Food and Drug Safety; approved as non-reimbursement from Health Insurance Review and Assessment Service; also, registration as new medical technology in Korea is in the progress.